Short-term effectiveness and safety of rituximab versus cyclophosphamide for life-threatening ANCA-associated vasculitis: a propensity score analysis of the real-world nationwide database
Yuichi Ishikawa, Kei Tokutsu, Shingo Nakayamada, Aya Kuchiba, Kiyohide Fushimi, Shinya Matsuda, Yoshiya Tanaka
Topics & Concepts
MedicineRituximabInternal medicinePropensity score matchingHazard ratioCyclophosphamideGranulomatosis with polyangiitisIncidence (geometry)VasculitisProportional hazards modelMicroscopic polyangiitisRapidly progressive glomerulonephritisDatabaseConfidence intervalChemotherapyLymphomaDiseaseComputer scienceOpticsPhysicsVasculitis and related conditionsSystemic Sclerosis and Related DiseasesOtitis Media and Relapsing Polychondritis